Contract Research & Services
Contract Research

Contract Research News

View news from other Pharmaceutical sectors:
1-15 of 2118 results
RXi Pharmaceuticals enters into research collaboration with Iovance Biotherapeutics
RXi Pharmaceuticals has partnered with Iovance Biotherapeutics to evaluate its sd-rxRNA therapeutic compounds with the latter’s autologous cell therapy based on tumor-infiltrating lymphocytes (TILs) for the use in the treatment of cancer.
Contract Research & Services > Contract Research > News
NetVation DL Medicine enters into research collaboration with Pfizer
Chinese biotechnology company NetVation DL Medicine, which is focused on the discovery and development of novel drug candidates, has entered into a two-year research collaboration with Pfizer.
Contract Research & Services > Contract Research > News
FDA puts Bellicum's cancer drug trials on clinical hold
By PBR Staff Writer
The US Food and Drug Administration (FDA) has placed clinical hold on Bellicum Pharmaceuticals' trials evaluating its cell therapy BPX-501 (genetically modified T cells) after reports of three cases of brain disease.
Contract Research & Services > Contract Research > News
Charles River acquires UK CRO KWS BioTest
By PBR Staff Writer
Charles River Laboratories International has acquired UK-based contract research organization (CRO) KWS BioTest for about £15m.
Contract Research & Services > Contract Research > News
Cue Biopharma forms research collaboration and signs license deal with Merck
Immunotherapy company Cue Biopharma has entered into a strategic research collaboration and license agreement with Merck.
Contract Research & Services > Contract Research > News
Merck cholesterol drug reduces heart risk by 9% in study
By PBR Staff Writer
Merck’s cardiovascular treatment anacetrapib has reduced the risk of major coronary events in the REVEAL study.
Contract Research & Services > Contract Research > News
Peregrine Pharmaceuticals cuts 20% of workforce to reduce costs
By PBR Staff Writer
Peregrine Pharmaceuticals has cut down its workforce by up to 20%, as part of its efforts to decrease costs and achieve overall profitability.
Contract Research & Services > Contract Research > News
HitGen, LEO Pharma form research collaboration
HitGen has entered into a multi-target multi-year research collaboration with LEO Pharma to discover novel small molecule leads for various therapeutic targets of interest to the latter.
Contract Research & Services > Contract Research > News
Prana partners with Takeda in Parkinson’s gastrointestinal neuropathology
Prana Biotechnology has entered into a research collaboration with Takeda Pharmaceuticals International to study the potential of its investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.
Contract Research & Services > Contract Research > News
Erytech, Queen’s University to advance eryminase program
Erytech Pharma and the Queen’s University in Canada have entered into a research collaboration to advance the preclinical development of the former’s eryminase program specifically for the treatment of arginase-1 deficiency.
Contract Research & Services > Contract Research > News
Daiichi Sankyo, Max Planck and Lead Discovery enter into cancer research collaboration
Daiichi Sankyo, Max Planck Innovation and the Lead Discovery Center have inked an agreement offering Daiichi Sankyo with the option to receive the exclusive rights to a new lead compound for cancer treatment to be discovered and developed at the Lead Discovery Center.
Contract Research & Services > Contract Research > News
Pamplona to buy US firm Parexel International for $5bn
By PBR Staff Writer
Pamplona Capital Management has agreed to acquire US-based biopharmaceutical services provider Parexel International for around $5bn.
Contract Research & Services > Contract Research > News
AbCellera partners with Sanofi Pasteur to advance influenza vaccine research
AbCellera has partnered with Sanofi Pasteur to advance the research and development of next-generation influenza vaccines.
Contract Research & Services > Contract Research > News
Carlyle, GTCR to buy Albany Molecular Research for $922m
By PBR Staff Writer
The Carlyle Group and GTCR have agreed to acquire global contract research and manufacturing organization, Albany Molecular Research (AMRI), for around $922m.
Contract Research & Services > Contract Research > News
Thermo Fisher to buy pharmaceutical CDMO Patheon for $7.2bn
By PBR Staff Writer
Thermo Fisher Scientific has agreed to acquire Patheon, a provider of drug development and delivery solutions to the pharmaceutical and biopharma sectors, for around $7.2bn.
Contract Research & Services > Contract Research > News
1-15 of 2118 results